2020
DOI: 10.20517/2347-8659.2020.29
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers for epileptogenesis in patients with autoimmune epilepsy

Abstract: Autoimmune epilepsy (AE) is a general term to describe recurrent seizures that have an immune-mediated origin. It is increasingly being recognized as a cause of epilepsy due to accumulating evidence supporting an immunemediated pathogenesis in patients who have shown resistance to traditional antiepileptic drugs (AEDs). The diagnosis of AE is one of the exclusions. Currently, there are no strict diagnostic guidelines for AE, and it is similarly under-recognized. The importance of early diagnosis of AE cannot b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 121 publications
(355 reference statements)
0
1
0
Order By: Relevance
“…Albeit apparently more uncertain, biomarkers could be utilized to distinguish and adequately treat pharmacoresistant epilepsy. In patients for whom no epileptogenic injury is recognized or whose EEG demonstrates no proof of epileptic form action, biomarkers are subtle [9]. For sure, our ability to anticipate seizure repeat after a first seizure-or foresee advancement of epilepsy after analysis of a possibly epileptogenic neurological affront (e. g., awful cerebrum injury and intracerebral discharge)-is very restricted if the MRI and EEG are unrevealing [10].…”
Section: Introductionmentioning
confidence: 99%
“…Albeit apparently more uncertain, biomarkers could be utilized to distinguish and adequately treat pharmacoresistant epilepsy. In patients for whom no epileptogenic injury is recognized or whose EEG demonstrates no proof of epileptic form action, biomarkers are subtle [9]. For sure, our ability to anticipate seizure repeat after a first seizure-or foresee advancement of epilepsy after analysis of a possibly epileptogenic neurological affront (e. g., awful cerebrum injury and intracerebral discharge)-is very restricted if the MRI and EEG are unrevealing [10].…”
Section: Introductionmentioning
confidence: 99%